A major, controlling role has been postulated for deoxyribonucleic acid (DNA)-dependent ribonucleic acid (RNA) polymerase (nucleoside triphosphate: RNA nucleotidyltransferase; EC 2.7.7.6) in the differential gene transcription that accompanies spore formation in Bacillus subtilis (21, 25) . The functional disappearance from vegetative polymerase of the sigma subunit early during sporulation results in a changed template specificity of the enzyme (3, 20) . This alteration of RNA polymerase structure and specificity, detected as a reduction in the ability to transcribe the DNA of phage oe, may be responsible not only for eliminating transcription of the DNA of phages that are unable to grow in sporulating cells (26) but also for shutting off those bacterial genes whose transcription is unique to the vegetative phase (16, 17) .
To explain the appearance during sporulation of transcripts absent from vegetative cells (1, 5, 28) , it has been proposed that sporulationspecific polypeptides might become associated with RNA polymerase after the end of growth and direct the. transcription of sporulationspecific genes. At least one sporulation-specific polypeptide that associates with RNA polymerase has been identified but no role in transcription can yet be ascribed to this protein (9) .
The study of RNA pqlymerase mutants resistant to the polymerase-specific antibiotic rifampin has supported the control by polymerase hypothesis. It was found that some rifampinresistant (RfmR) mutants failed to sporulate or formed abnormal spores (6, 25) . Since the growth of these mutants was not affected by the mutation, it was concluded that interactions involving at least some component of RNA polymerase determine ability to sporulate. The finding that in these nonsporulating mutants the template specificity of RNA polymerase did not change as much as in the wild type after the end of growth strongly suggested that in the wild-type strain the alteration of polymerase specificity is or is indicative of a primary event in transcriptional control (25) . Since the completion of those early studies, we have investigated in depth the properties of two kinds of RNA polymerase mutants, i.e., mutants resistant to either rifampin or streptolydigin (Std), and present here the results of those investigations.
The study of rifampin and streptolydiginresistant mutants of'Escherichia coli has proved useful in studying the mechanism of transcription and its control during growth and phage infection (11, 23, 29) . We have undertaken this study in an attempt to clarify the relationship between vegetative and sporulation components of B. subtilis RNA polymerase and in the hope that the techniques of genetic analysis will offer new insights into the functioning of the enzyme and suggest new avenues for biochemical work. A preliminary report of these investigations has been presented (24) . M.
Transformation basal medium (T base) contained 2 g of (NH4)ISO4, 14 g of K2HPO4, 6 g of KH2PO4, and 1 g of trisodium citrate dihydrate per liter. For SpC medium, T base was supplemented with 0.02% MgSO4, 0.5% glucose, 0.025% casein hydrolysate, and 0.005% required amino acids. SpT medium was the same as SpC except that the concentrations of casein hydrolysate and required amino acids were reduced to 0.01 and 0.0005%, respectively. For slowgrowing strains, nutrient broth was frequently added to SpC and SpT media to 0.1 or 0.2%. Top agar was 0.8% nutrient broth, 0.5% NaCl, and 0.65% agar. Tryptose blood agar base was obtained from Difco and prepared according to the manufacturer's instructions.
Mutagenesis. For mutagenesis by ultraviolet light an overnight culture of B. subtilis 3610 in medium 121A was washed and resuspended in basal medium 121 at a concentration of 2 x 109 cells per ml. A 2-ml sample was exposed for 2 min to ultraviolet irradiation (15 W GE germicidal lamp at a distance of 50 cm) in an uncovered petri dish. The irradiated culture was spread on TBAB plates containing 5 jAg of rifampin per ml which were then incubated overnight at 37 C in the dark. Survival to this dose of irradiation was 0.3%.
Ethyl methane sulfonate (EMS) mutagenesis of B. subtilis 168 Ura-was as follows. An overnight culture in L medium supplemented with 0.001% tryptophan and 100 MM uracil was diluted 100-fold into fresh medium. This culture was shaken at 30 C until a bacterial density of about 5 x 107 cells per ml was reached. EMS was added to 1% final concentration and the mixture was shaken vigorously at 30 C for 3 h. After having been centrifuged and washed three times with fresh medium, the cells were resuspended in supplemented L medium at a bacterial density of 5 x 107/ml and shaken overnight at 30 C to allow expression of EMS-induced mutations. This segregated culture was washed with basal medium 121, resuspended in 121 containing 15% glycerol and stored in small portions at -15 C. As needed, samples were thawed and plated to determine mutation frequencies or to isolate rifampin-resistant mutants. In a typical experiment, EMS treatment raised the frequency of mutation to RfmR from 10-7 to 3 x 10-6. In the same experiment, reversion of the Trp-phenotype of strain 168 Ura-was raised from less than 2 x 10-8 to 10-7 but reversion of the Ura-phenotype was unaffected.
For mutagenesis with 2-aminopurine (AP), single colonies of strain 3610 were inoculated into tubes containing 2.5 ml of medium 121A supplemented with 40 Mg of FeCl.-trisodium citrate per ml and 0.05% 2-aminopurine. The tubes were shaken overnight at 32 C. Samples were plated on DSM containing rifampin (5 Mg/ml). In a typical experiment the frequency of mutation to RfmR was raised from 2 x 10-' to 2 x Measurement of sporulation-related properties.
Spore formation was measured by determining the survival to heating for 10 min at 80 C of a sample of a culture that had been shaken at least 10 h beyond the end of logarithmic growth phase.
Antibiotic, serine protease, and esterase productions, regulation of nitrate reductase, sensitivity to polymyxin B, anct competence in transformation were determined by methods in the literature (see ref. 19 ). Stage of blockage of sporulation was kindly identified for us by electron microscopy by A. Ryter.
Bacterial extracts and RNA polymerase assays. Extracts of log phase and sporulating bacteria were prepared in DSM or 121B media as previously described (3, 21) . Partial purification of RNA polymerase by ammonium sulfate precipitation, preparation of template DNAs, and assay of RNA polymerase were as described (3) . To determine template specificity changes the ratio of RNA polymerase activity with oe DNA and poly d(AT) was compared for extracts of log phase and sporulating cells.
Transformation. Competent cells were prepared by inoculating SpC medium to a density of about 108 per milliliter with bacteria from a culture streaked on TBAB and incubated the previous night at 37 C. The SpC culture was grown for 4 to 5 h at 37 C or until the end of log phase. A 10-fold dilution of the culture into SpT medium was incubated with shaking at 37 C for 70 min. DNA was then added and, after 30 min further incubation, the transformation was terminated by the addition of deoxyribonuclease (DNase) I. For transformation of auxotrophic strains to prototophy the transformed culture was plated directly on selective agar. In cases where drug resistance was selected a double-layer technique was used. A sample of the transformed culture was added to 2.5 ml of top agar and poured over a DSM plate. These plates were incubated at 37 C for 2 to 2.5 h when rifampin or streptolydigin resistance was being selected and for 3 h when streptomycin resistance was being selected to allow expression of newly acquired resistances. An appropriate dilution of the drug was then added to 2.5 ml of top agar and poured over the preincubated plates. Primary transformants were purified at least once by streaking on selective agar. Purified transformants were then tested by replica plating for unselected markers.
Transforming DNA was extracted from brothgrown cells after breaking the cells with lysozyme and sodium dodecyl sulfate. A volume of phenol (Mallinckrodt, 88%) equal to that of the extract was added and the mixture was shaken at 4 C for 20 min. The phases were separated by centrifugation and nucleic acid was precipitated from the aqueous phase with 2 volumes of ice-cold 95% ethanol. The nucleic acid was dissolved in 0.015 M NaCl-0.0015 M Na, citrate, pH 7.0, and treated with ribonuclease (RNase) (50 Ag/ml) for 30 min at 37 C. After reextraction with phenol and precipitation with ethanol, the DNA was finally dissolved in 0.85% NaCl. DNA concentrations were determined either by the diphenylamine test (4) or by measuring the limit digest of the DNA by DNase I. For experiments in which DNA was to be limiting a maximum of 0.03 gg/ml was used; for saturating DNA a minimum of 1 Mg/ml was used.
Transduction. Transductions with phage PBS1 were carried out as described by Hoch et al. (14) .
RNA POLYMERASE MUTANTS
Measurements of phage infection. Efficiency of plating (EOP) was defined as the ability of a mutant relative to the parent strain to allow plaque formation by phage Oe. Mutants and parent strains were grown in L broth to mid-log phase. A 0.1-ml portion of the culture was combined with 0.1 ml of an appropriate phage dilution and 2.5 ml of top agar and poured over the surface of an L plate. Plates were incubated ovemight at 30 C.
To determine the efficiency of infective center production or efficiency of transmission (EOT), log phase cells in DSM (for 168 derivatives) or 121A (for 3610 derivatives) were infected with a multiplicity of infection of 0.05 to 0.1 and were allowed to shake 10 min at 37 C. A diluted sample was imbedded in top agar with 10 spores of 3610 as indicator, poured over an L plate, and incubated at 30 C.
Adsorption and burst size were determined as described by Sonenshein and Roscoe (26) with the following exceptions: (i) 3610 derivatives were grown in 121A medium and 168 derivatives in DSM; and (ii) antiserum treatment was replaced by centrifugation at room temperature for 5 min at 5,000 rpm followed by dilution 10,000-fold in fresh medium.
Chemicals (12) have reported a similar increase in RfmR mutants after treatment of spores with EMS. As will be shown below, RfmR mutants isolated from four different parent strains behave similarly in tests of in vitro resistance to the drug and genetic linkage. We have never detected any difference in the properties of mutants isolated after challenge by rifampin compared with those arising after challenge by rifamycin SV. The RfmR mutants we have isolated are stably altered since they retain their drug-resistance after being cultured in drug-free medium.
Strain 168 has an efficiency of colony formation of 10-6 on plates containing 40 Mg of streptolydigin per ml. Most of the colony formers are stably resistant to the drug.
To test for in vivo cross-resistance the RfmR strains LS 3, LS 4, MO 20, MO 29, MO 32, and MO 33 were streaked on DSM plates containing 40 Mg of streptolydigin per ml; they failed to grow. Similarly, when StdR strains MO 34, MO 36, MO 37, and MO 38 were streaked on DSM containing 5 Mg of rifampin per ml, only strain MO 38 grew. Thus, in vivo cross-resistance is at most limited.
In vitro resistance of mutants. To exclude mutants in which resistance was due to lack of uptake of the given drug, extracts of growing cells of many RfmR and StdR mutants were examined for drug-resistant RNA synthesis in vitro. The extracts were partially purified by ammonium sulfate fractionation to make RNA synthesis dependent on added DNA. As shown in Fig. 1A , all of the RfmR mutants tested in vitro were resistant to 100-to 1,000-fold higher concentrations of the drug than were the parent strains. We have not isolated RfmR mutants of B. subtilis that failed to demonstrate drugresistant activity in vitro. StdR mutants were also tested for in vitro resistance (Fig. 1B) . Many mutants were as sensitive in vitro as the parent strain, but those that were significantly more resistant resisted 10 to 100 times more drug than did their parents. Thus, the mutants discussed here are likely to be mutated in a gene coding for a subunit of DNA-dependent RNA polymerase. Extracts prepared from cells of all these same strains harvested four to five hours after the end of growth showed similar resistance patterns.
Strain MO 38 is the only strain that definitely produces an RNA polymerase that is resistant to both rifampin and streptolydigin in vitro ( Fig. 1B and 1C) . Genetic (7, 15, 27 (Table 7) . Of these strains, two were studied in more detail. As shown in Table 7 higher than their normal heat resistance.
A situation essentially similar to that for strain LS 3 has been found to obtain for strains LS 12, LS 13, MO 27, and MO 29. We do not know the origin of the slow expression of the Spo-phenotype compared to RfmR. However, it is reminiscent of the phenomena of transient mero-diploidy observed for trpE26 and certain Spo-mutations (2, 18).
Mapping of ]RNA polymerase mutants.
Harford and Sueoka (11) reported that three Rfm R mutations of B. subtilis mapped between cysA14 and str-1, and Haworth and Brown (12) have more recently reported the linkage of a series of RfmR and StdR mutations to cysA14 and determined the order of the genes as cysA14-rfm-std. We have mapped RfmR and StdR mutations of classes I, II, and III with respect to cysA14 and str-1 and with respect to each other.
A limited number of rfm mutations were examined for linkage to cysA14 in two-factor transduction experiments with phage PBS1. The mutations rfm-84, rfm-495, rfm-67, rfm-466, rfm-446, rfm-326Y, rfm-336Y, and rfm-3Y were all co-transduced with cysA14 at high frequency. We have now examined 21 Tables 8  to 10 . From Table 8 it can be seen that the mutations rfm-84, rfm-495, rfm-22, rfm-67, rfm-466, rfm-76, rfm-1108, std-4, and std-9 all lie between cysA14 and str-1. Since std-445 lies between all rfm markers tested and str-1 it can be inferred that it too lies to the right of cysA14 (Table 10) .
With the exception of std-3, all std markers tested lie between str-1 and any given rfm marker. This is true for rfm and std markers of Probable order: rfm-76-(std-4, std-3, std-9)-str-l a Donor and recipient phenotypes are indicated by "1" and "0" respectively.
class I (rfm-495 and std-445), class II (rfm-84 and std-4), and class III (rfm-466). The mutation std-3 cannot be located with certainty. On the one hand it is probably between rfm and str-1 (see Table 9 a and c) and in two-and three-factor transformations it is the std marker located the farthest from cysA14 and the nearest to str-1. Yet as seen in Table 8b the "101" recombinant class is not the least frequent. Similarly, in Table 9b , std-3 cannot be shown to be between rfm-495 and str-1. Taking the least frequent class of recombinants as representative of the largest number of recombination events, the only order consistent with the data of Tables  8b and 9b would be std-3-cysA14-rfm-495-str-1. This is not at all in accord with the linkage data which show that std-3 is linked to the other three markers and of them most closely linked to str-1. The cause of these anomalous findings is unknown, but it cannot be excluded that one Probable order: str-l-std-445-rfm-500 a Donor and recipient phenotypes are indicated by "1" and "0" respectively. resistance mutation may be poorly expressed in the presence of another.
Our data do not permit us to decide whether the different classes of mutations are clustered. Finer mapping among RfmR and StdR mutants is required and is in progress. We can conclude tentatively that rfm and std represent non-overlapping, linked loci but cannot yet determine whether these loci are located in one or more than one cistron. That all rfm and std mutations, including spontaneous, revertable mutations, map in the same small region of the chromosome strongly suggests that there is a unique sequence of bases located between cysA14 and str-1 at which mutation to RfmR and StdR can occur. Assuming that rfm and std are mutations in a gene coding for a subunit(s) of RNA polymerase, it may be expected that genes coding for other subunits of the enzyme may be closely linked. It is interesting to note that the genetic distance between cysA14 and str-1 corresponds roughly to the amount of DNA necessary to code for one copy of all the known subunits of B. subtilis RNA polymerase.
Since linkage in any given experiment depends on the integrity and average size of the transforming DNA, we have not tried to construct a detailed map of the cysAl4-str-1 region.
Rather we present in Fig. 2 a tentative map based on selected data derived from cases where standard distances were simultaneously determined. By comparing part A of Fig. 2 with Map unit distance = 100% -percent co-transformation.
VOL. 120, 1974 is a property of the core polymerase (J. Brevet, unpublished data). Class II mutants, which represent a substantial minority class of those occurring spontaneously, grow normally in the presence of the drug to which they are resistant, but fail to sporulate whether the drug is present or not. The existence of this class is strong evidence for the control-by-polymerase hypothesis since a mutation in a gene coding for an RNA polymerase subunit interferes with the timely expression of sporulation functions without blocking the expression of functions required for growth. The most likely explanation for this phenotype is that it is the transcriptional activity of RNA polymerase that is interfered with, causing the enzyme to be unable to recognize promoter sites for sporulation functions. We cannot, however, rule out alternative models in which the RfmR and StdR subunits of DNA-dependent RNA polymerase might play some undefined nontranscriptive role in sporulation. The enzyme from strain LS 3 has been purified by phosphocellulose chromatography. As for class I mutants, rifampin resistance in this case was a property of the core enzyme (A. L. Sonenshein, unpublished data).
One of the class II mutants (MO 36) changed the template specificity of RNA polymerase after the end of growth but most did not. The simplest explanation for this behavior is that those that did not change in template specificity failed to sporulate because of this defect, which could arise if by mutation the binding of vegetative sigma factor to core polymerase were greatly increased. For strain MO 36 it is likely that other changes in the structure, activity, or specificity of DNA-directed transcription are required for successful sporulation. A possibility to be considered is that the RNA polymerase of this mutant is unable to accommodate proteins synthesized after the end of growth and required for sporulation-specific transcription.
A preliminary report by Nishimoto and Takahashi (22) suggested that a particular stage II asporogenous mutant, Spo II 46-7 (also known as Spo II 1), failed to change the in vitro template specificity of RNA polymerase after the end of growth. This mutant strain has a complex growth pattern and the fraction of the population that actually reaches stage II has not been documented. Even if further work supports the initial finding, this suggestion cannot be taken to imply that the change in template specificity depends on successful completion of all stage II functions. Such an argument requires the assumption that biochemical events and morphological changes are linked by a single, sequential pathway, the interruption of which at any point blocks all further progress toward sporulation. We consider this assumption unlikely and prefer the hypothesis that morphological changes derive from branches of independent biochemical pathways. Viewed in this way, it can be seen that all the gene expression required to attain the morphological stage II might occur within the first few minutes of sporulation. The mutation in this strain, therefore, could be in a gene coding for a function that normally acts very early in development.
The existence of mutants that grow well in the presence of rifampin or streptolydigin but sporulate much less well when exposed to 10 rifampin-resistant, streptovaricin-resistant (StvR), and streptolydiginresistant mutants and found them all to be co-transduced at high frequency with cysA14. By using transformation, the same authors established the gene order cysA14-(rfm, stv)-std. In these studies, RNA polymerase mutants of undefined sporulation phenotype were used. We have presented similar data for RfmR and StdR mutants of three different classes with respect to sporulation.
The existence of different classes of RfmR and StdR mutants with respect to support of sporulation and phage infection indicates that the change in DNA base sequence that can give rise to resistance to either drug is far from unique and allows one to speculate that amino acid substitutions at multiple sites in the same RNA polymerase subunit or in more than one subunit may be involved. To understand more clearly the distinctions between the various mutant classes, we are currently investigating the site of mutation in all classes of RfmR and StdR mutants by fine structure mapping and reconstitution experiments with isolated enzyme subunits.
